Abstract
Split First Dose Administration of Daratumumab for the Treatment of Patients with Multiple Myeloma (MM): Clinical Pharmacology and Population Pharmacokinetic (PK) Analyses
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have